Drug intelligence / Profile preview

ClickCRM

Development stage
Unknown
Lead developer
VALANX Biotech
Modality
Recombinant Proteins and Enzymes
Administration
Parenteral (as Component In Injectable Vaccine Formulations)
01

Overview

ClickCRM is a ready-to-conjugate version of CRM197, an antigenic carrier protein widely used in the development of conjugate vaccines. It is engineered for rapid and high-efficiency conjugation to polysaccharide antigens, enabling the generation of conjugate vaccines with improved immunogenicity compared to traditional polysaccharide vaccines. The product features defined conjugation sites created by incorporating synthetic amino acids compatible with third-generation click chemistry, allowing precise site-specific protein modification. This technology facilitates accurate and efficient attachment of antigens to CRM197, streamlining vaccine development processes for bacterial infections such as those targeted by pneumococcal and meningococcal vaccines. Developed using synthetic biology approaches, ClickCRM leverages proprietary platform technologies from VALANX Biotech for upstream production (incorporating non-natural amino acids) and Fina Biosolutions' methods for purification and formulation[1][2][6].

Brand names
ClickCRM
Other names
ClickCRM
02

Targets

TCO-antigen (Trans-cyclooctene-modified antigen)

Beyond the preview

Go deeper on ClickCRM.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ClickCRM.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call